104 related articles for article (PubMed ID: 30802285)
1. Pegylated Human Leptin D23L Mutant-Preparation and Biological Activity In Vitro and In Vivo in Male ob/ob Mice.
Gertler A; Solomon G
Endocrinology; 2019 Apr; 160(4):891-898. PubMed ID: 30802285
[TBL] [Abstract][Full Text] [Related]
2. Large-scale preparation and characterization of non-pegylated and pegylated superactive ovine leptin antagonist.
Niv-Spector L; Shpilman M; Boisclair Y; Gertler A
Protein Expr Purif; 2012 Feb; 81(2):186-92. PubMed ID: 22040607
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of high affinity leptins and leptin antagonists.
Shpilman M; Niv-Spector L; Katz M; Varol C; Solomon G; Ayalon-Soffer M; Boder E; Halpern Z; Elinav E; Gertler A
J Biol Chem; 2011 Feb; 286(6):4429-42. PubMed ID: 21119198
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of leptin fragments activity on the ob receptor.
de Oliveira VX; Fázio MA; Santos EL; Pesquero JB; Miranda A
J Pept Sci; 2008 May; 14(5):617-25. PubMed ID: 18008380
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of new leptin fragments on food intake and body weight of normal rats.
Martins MN; Telles MM; Zemdegs JC; Andrade IS; Ribeiro EB; Miranda A
Regul Pept; 2009 Feb; 153(1-3):77-82. PubMed ID: 19100785
[TBL] [Abstract][Full Text] [Related]
6. [D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice.
Grasso P; Rozhavskaya-Arena M; Leinung MC; Lee DW
Regul Pept; 2001 Sep; 101(1-3):123-9. PubMed ID: 11495687
[TBL] [Abstract][Full Text] [Related]
7. Leptin is a potent stimulator of bone growth in ob/ob mice.
Steppan CM; Crawford DT; Chidsey-Frink KL; Ke H; Swick AG
Regul Pept; 2000 Aug; 92(1-3):73-8. PubMed ID: 11024568
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute changes in neonatal leptin levels on food intake and long-term metabolic profiles in rats.
Granado M; García-Cáceres C; Fuente-Martín E; Díaz F; Mela V; Viveros MP; Argente J; Chowen JA
Endocrinology; 2011 Nov; 152(11):4116-26. PubMed ID: 21933868
[TBL] [Abstract][Full Text] [Related]
9. A superactive leptin antagonist alters metabolism and locomotion in high-leptin mice.
Chapnik N; Solomon G; Genzer Y; Miskin R; Gertler A; Froy O
J Endocrinol; 2013 Jun; 217(3):283-90. PubMed ID: 23482705
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of leptin-related synthetic peptides on body weight and food intake in female ob/ob mice: localization of leptin activity to domains between amino acid residues 106-140.
Grasso P; Leinung MC; Ingher SP; Lee DW
Endocrinology; 1997 Apr; 138(4):1413-8. PubMed ID: 9075696
[TBL] [Abstract][Full Text] [Related]
11. Improvement of insulin resistance by removal of systemic hydrogen peroxide by PEGylated catalase in obese mice.
Ikemura M; Nishikawa M; Hyoudou K; Kobayashi Y; Yamashita F; Hashida M
Mol Pharm; 2010 Dec; 7(6):2069-76. PubMed ID: 21033698
[TBL] [Abstract][Full Text] [Related]
12. Preparation of Potent Leptin Receptor Antagonists and Their Therapeutic Use in Mouse Models of Uremic Cachexia and Kidney Fibrosis.
Mak RH; Cheung WW; Solomon G; Gertler A
Curr Pharm Des; 2018; 24(9):1012-1018. PubMed ID: 29366406
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of leptin-related synthetic peptide 116-130 on food intake and body weight gain in female C57BL/6J ob/ob mice may not be mediated by peptide activation of the long isoform of the leptin receptor.
Grasso P; White DW; Tartaglia LA; Leinung MC; Lee DW
Diabetes; 1999 Nov; 48(11):2204-9. PubMed ID: 10535455
[TBL] [Abstract][Full Text] [Related]
14. Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men.
Westerterp-Plantenga MS; Saris WH; Hukshorn CJ; Campfield LA
Am J Clin Nutr; 2001 Oct; 74(4):426-34. PubMed ID: 11566639
[TBL] [Abstract][Full Text] [Related]
15. Pegylated leptin antagonist with strong orexigenic activity in mice is not effective in chickens.
Gertler A; Shinder D; Yosefi S; Shpilman M; Rosenblum CI; Ruzal M; Seroussi E; Friedman-Einat M
J Exp Biol; 2014 Jan; 217(Pt 2):180-4. PubMed ID: 24115063
[TBL] [Abstract][Full Text] [Related]
16. The effect of leptin on the ventilatory responseto hyperoxia.
Groeben H; Meier S; Brown RH; O'Donnell CP; Mitzner W; Tankersley CG
Exp Lung Res; 2004; 30(7):559-70. PubMed ID: 15371092
[TBL] [Abstract][Full Text] [Related]
17. Biological activities of recombinant chicken leptin C4S analog compared with unmodified leptins.
Dridi S; Raver N; Gussakovsky EE; Derouet M; Picard M; Gertler A; Taouis M
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E116-23. PubMed ID: 10893330
[TBL] [Abstract][Full Text] [Related]
18. Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity.
Elinav E; Niv-Spector L; Katz M; Price TO; Ali M; Yacobovitz M; Solomon G; Reicher S; Lynch JL; Halpern Z; Banks WA; Gertler A
Endocrinology; 2009 Jul; 150(7):3083-91. PubMed ID: 19342450
[TBL] [Abstract][Full Text] [Related]
19. Preparation of leptin antagonists by site-directed mutagenesis of human, ovine, rat, and mouse leptin's site III: implications on blocking undesired leptin action in vivo.
Solomon G; Niv-Spector L; Gonen-Berger D; Callebaut I; Djiane J; Gertler A
Ann N Y Acad Sci; 2006 Dec; 1091():531-9. PubMed ID: 17341642
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of recombinant pufferfish (Takifugu rubripes) leptin.
Yacobovitz M; Solomon G; Gusakovsky EE; Levavi-Sivan B; Gertler A
Gen Comp Endocrinol; 2008 Mar; 156(1):83-90. PubMed ID: 18191858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
